Table 2.
Group | PID | Age | CD4 count (cells/μl) |
HIV viral load (RNA copies/ml) |
Ex vivo cervical cell count |
---|---|---|---|---|---|
Anti-CD3/IL-2 | 1 | 26 | 703 | < 50 | 117,320 |
2 | 26 | 384 | 13,000 | 96,800 | |
3 | 33 | 465 | 170,000 | 110,800 | |
4 | 42 | 601 | < 50 | 98,050 | |
5 | 31 | 302 | 120,000 | 94,800 | |
6a | 34 | 552 | 13,000 | 112,356 | |
Dynal(1:1)/IL-2 | 7 | 33 | 473 | < 50 | 118,800 |
8 | 34 | 310 | 8100 | 121,800 | |
9 | 43 | 605 | < 50 | 94,800 | |
10 | 32 | 811 | < 50 | 156,000 | |
11 | 36 | 389 | < 50 | 91,320 | |
12a | 40 | 353 | 160,000 | 128,560 | |
13a | 37 | 306 | 6000 | 132,000 | |
Dynal(1:1)/IL-2/IL-7/IL-15 | 14 | 41 | 396 | 1600 | 124,800 |
15 | 41 | 312 | < 50 | 112,800 | |
16 | 31 | 302 | 120,000 | 92,800 | |
17 | 40 | 401 | 22,000 | 142,000 | |
18 | 36 | 308 | 16,000 | 101,320 | |
Median | 34 | 396 | 6000 | 112,800 | |
Range | 26–43 | 302–811 | < 50–170,000 | 91,320–156,000 |
Cervical cytobrush samples became contaminated during expansion.